The Singapore facility is part of Sanofi's 900 million euro investment to develop two new EVFs globally over five years. The other facility is in Neuville-sur-Saône, France. SINGAPORE — French ...
Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products and could be used to respond to an emerging pandemic ...